Pharmacokinetics of cefixime in patients with impaired renal function

Cefixime (CFIX) was given orally in a single dose of 100 mg to 7 patients with varying degrees of impaired renal function (Ccr 12.0-56.7 ml/min) and serum concentrations and urinary excretion rates were measured with time for the first 24 hours by the bioassay method to investigate in vivo pharmacok...

Full description

Saved in:
Bibliographic Details
Published in:Japanese journal of antibiotics Vol. 39; no. 10; p. 2716
Main Authors: Maeda, H, Sako, M, Fujii, A, Yamazaki, H, Kawabata, G, Harada, M, Arakawa, S, Umezu, K, Kamidono, S, Ishigami, J
Format: Journal Article
Language:Japanese
Published: Japan 01-10-1986
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Cefixime (CFIX) was given orally in a single dose of 100 mg to 7 patients with varying degrees of impaired renal function (Ccr 12.0-56.7 ml/min) and serum concentrations and urinary excretion rates were measured with time for the first 24 hours by the bioassay method to investigate in vivo pharmacokinetics of the drug. The results obtained are summarized as follows. The mean peak serum concentration of CFIX in 3 patients with moderately impaired renal function (group I: Ccr greater than or equal to 30-less than 60 ml/min) was 2.04 micrograms/ml at 6 hours after dosing and gradually declined to 0.10 microgram/ml at 24 hours after dosing. The half-life was 4.15 hours. The mean peak serum concentration of CFIX achieved was 2.27 micrograms/ml at 8 hours after dosing in 4 patients with severely impaired renal function (group II: Ccr greater than or equal to 10-less than 30 ml/min) and the concentration of CFIX was 0.99 microgram/ml even after 24 hours. The half-life was prolonged to 11.05 hours. There was no great difference between groups I and II in the first 24-hour urinary excretion rates. However, the first 4-hour urinary excretion accounted for 2.14% of the administered dose of CFIX in group I but only 0.47% in group II. Urinary concentrations of CFIX peaked at 4-6 hours after dosing in both groups, and thereafter gradually decreased in group I. Whereas, they did not decline much in group II until 24 hours after dosing.(ABSTRACT TRUNCATED AT 250 WORDS)
AbstractList Cefixime (CFIX) was given orally in a single dose of 100 mg to 7 patients with varying degrees of impaired renal function (Ccr 12.0-56.7 ml/min) and serum concentrations and urinary excretion rates were measured with time for the first 24 hours by the bioassay method to investigate in vivo pharmacokinetics of the drug. The results obtained are summarized as follows. The mean peak serum concentration of CFIX in 3 patients with moderately impaired renal function (group I: Ccr greater than or equal to 30-less than 60 ml/min) was 2.04 micrograms/ml at 6 hours after dosing and gradually declined to 0.10 microgram/ml at 24 hours after dosing. The half-life was 4.15 hours. The mean peak serum concentration of CFIX achieved was 2.27 micrograms/ml at 8 hours after dosing in 4 patients with severely impaired renal function (group II: Ccr greater than or equal to 10-less than 30 ml/min) and the concentration of CFIX was 0.99 microgram/ml even after 24 hours. The half-life was prolonged to 11.05 hours. There was no great difference between groups I and II in the first 24-hour urinary excretion rates. However, the first 4-hour urinary excretion accounted for 2.14% of the administered dose of CFIX in group I but only 0.47% in group II. Urinary concentrations of CFIX peaked at 4-6 hours after dosing in both groups, and thereafter gradually decreased in group I. Whereas, they did not decline much in group II until 24 hours after dosing.(ABSTRACT TRUNCATED AT 250 WORDS)
Author Ishigami, J
Arakawa, S
Sako, M
Fujii, A
Maeda, H
Kawabata, G
Kamidono, S
Yamazaki, H
Umezu, K
Harada, M
Author_xml – sequence: 1
  givenname: H
  surname: Maeda
  fullname: Maeda, H
– sequence: 2
  givenname: M
  surname: Sako
  fullname: Sako, M
– sequence: 3
  givenname: A
  surname: Fujii
  fullname: Fujii, A
– sequence: 4
  givenname: H
  surname: Yamazaki
  fullname: Yamazaki, H
– sequence: 5
  givenname: G
  surname: Kawabata
  fullname: Kawabata, G
– sequence: 6
  givenname: M
  surname: Harada
  fullname: Harada, M
– sequence: 7
  givenname: S
  surname: Arakawa
  fullname: Arakawa, S
– sequence: 8
  givenname: K
  surname: Umezu
  fullname: Umezu, K
– sequence: 9
  givenname: S
  surname: Kamidono
  fullname: Kamidono, S
– sequence: 10
  givenname: J
  surname: Ishigami
  fullname: Ishigami, J
BackLink https://www.ncbi.nlm.nih.gov/pubmed/3806957$$D View this record in MEDLINE/PubMed
BookMark eNotj8tKAzEUQLOo1Fr7CUL8gKnJTWeSLKVUKxR0oeuSxw292skMMynq36vY1YGzOHCu2CR3GRm7lWIpZV2rO5cLeeoKhVHaxvilskvQspmwmVCNqUAbeckW40heCDAgra2nbKqMaGytZ2zzcnBD60L3QRn_KrxLPGCiL2qRU-a9K4S5jPyTyoFT2zsaMPIBszvydMqhUJev2UVyxxEXZ87Z28Pmdb2tds-PT-v7XfUuAXTVWC8BY6oFRuHRCIUQNATnlbcrXScA4X611yFaFbBREoV0OqSVMNF6mLOb_25_8i3GfT9Q64bv_XkHfgBHPFJ4
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.11553/antibiotics1968b.39.2716
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
ExternalDocumentID 3806957
Genre English Abstract
Journal Article
GroupedDBID .55
.LE
3O-
53G
5GY
7.U
8GM
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
ECM
EIF
F5P
JSF
JSH
KQ8
NPM
OK1
RJT
RZJ
SJN
TKC
X7J
X7M
ZJWQK
ZXP
ID FETCH-LOGICAL-j1227-69b12edf50ed0be803e2c72cab3b9475f220ae80b7cd93ce631e01a7cf408d9b2
ISSN 0368-2781
IngestDate Thu May 23 22:58:15 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j1227-69b12edf50ed0be803e2c72cab3b9475f220ae80b7cd93ce631e01a7cf408d9b2
OpenAccessLink https://www.jstage.jst.go.jp/article/antibiotics1968b/39/10/39_2716/_article/-char/en
PMID 3806957
ParticipantIDs pubmed_primary_3806957
PublicationCentury 1900
PublicationDate 1986-Oct
PublicationDateYYYYMMDD 1986-10-01
PublicationDate_xml – month: 10
  year: 1986
  text: 1986-Oct
PublicationDecade 1980
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Japanese journal of antibiotics
PublicationTitleAlternate Jpn J Antibiot
PublicationYear 1986
SSID ssib002821995
ssj0000884033
Score 1.3345686
Snippet Cefixime (CFIX) was given orally in a single dose of 100 mg to 7 patients with varying degrees of impaired renal function (Ccr 12.0-56.7 ml/min) and serum...
SourceID pubmed
SourceType Index Database
StartPage 2716
SubjectTerms Administration, Oral
Adult
Aged
Cefixime
Cefotaxime - administration & dosage
Cefotaxime - analogs & derivatives
Cefotaxime - metabolism
Drug Administration Schedule
Female
Half-Life
Humans
Kidney Diseases - drug therapy
Kidney Diseases - metabolism
Kinetics
Male
Middle Aged
Title Pharmacokinetics of cefixime in patients with impaired renal function
URI https://www.ncbi.nlm.nih.gov/pubmed/3806957
Volume 39
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bS-QwFA4zKy6-iJeV9UoE8cnupmnatI-LjviiCI6gT5JboSMzI6uC-us9aZJpZ0TRB19KSWinzfdNcnJ6zncQ2uPKJlzmMkrjMo8Y1UUkNGxWmE64YEIQZuwX3ZMLfnaVH_VYr9MJcVxN27ciDW2Atc2c_QLak5tCA5wD5nAE1OH4KdzPvRb1LZiPtQSzjRs3ZfVUDWt9EC-k6rPabJJkZUPQ_xtrltpVboJUMFlhObVlKtsiEwBHJavxQytU_lQYLaayHS7E7XjK33r8OKiqKf_ptRiKF9GqnO0cEHGRZ5NQtibxCiDgrvJKmFSdQlEgD2lPkdwlV76du9O6AkfrDWB2yOUfm080cw0M-d2wBjDJSVY4iesPO2dEtX1PF3XBQrJG9GHj44FNqM1bn3jqYB5mJHF1tv2b_kS74Yn_vve8C2je_8rMjqW2XPpLaNFvOfA_x5Vl1BmIFbTvefJ8gPtNCt79Ad7H542a-fMq6s0SCo9LHAiFqxEOhMKWUDgQCteEwoFQv9Dlca9_eBL52hvRIKaUR1khY2p0mRKjiTQ5SQxVnCohE1kwnpaUEgHNkitdJMpkSWxILLgqGcl1Ieka-jEaj8xvhLnimZKCS5kyWC7AQDRgF1Km4E4pLMbraM0Nz82dE1i58eO28V7HJlpoiLiF5kr475pt1L3Xjzs1lq9YL2KW
link.rule.ids 782
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacokinetics+of+cefixime+in+patients+with+impaired+renal+function&rft.jtitle=Japanese+journal+of+antibiotics&rft.au=Maeda%2C+H&rft.au=Sako%2C+M&rft.au=Fujii%2C+A&rft.au=Yamazaki%2C+H&rft.date=1986-10-01&rft.issn=0368-2781&rft.volume=39&rft.issue=10&rft.spage=2716&rft_id=info:doi/10.11553%2Fantibiotics1968b.39.2716&rft_id=info%3Apmid%2F3806957&rft_id=info%3Apmid%2F3806957&rft.externalDocID=3806957
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0368-2781&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0368-2781&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0368-2781&client=summon